AFFiRiS AG

14 May 2018. AFFiRiS Announces Encouraging Long-term Data from a Series of First-in-Human Studies Using AFFITOPE ® PD01A Targeting Oligomeric Alpha-synuclein in Early Parkinson’s Disease Patients. Company profile page for AFFiRiS AG including stock price, company news, press releases, executives, board members, and contact information. AFFiRiS AG renders biotechnology services. The Company researches and develops customized therapeutic peptide-based vaccines targeting chronic diseases including Alzheimers, Parkinsons ...

Ionis Pharmaceuticals

Aug 24, 2019 · Ionis Pharmaceuticals , Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. Ionis Pharmaceuticals , Inc., incorporated on March 25, 1991, is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company, using its drug discovery platform ... See the company profile for Ionis Pharmaceuticals , Inc. (IONS) including business summary, industry/sector information, number of employees, business …

Inc.

An Inc. Verified Profile is the perfect tool for helping entrepreneurs and small companies showcase their companies in attention-grabbing context. Whether you want to drum up new customers, seek ... Aug 24, 2019 · Immunic Inc . company facts, information and stock details by MarketWatch. View imux business summary and other industry information. The first Canadian company to combine investigations, screening and security systems under one roof Since 1990, we’ve been helping Canadian organizations protect their business – and their bottom line. Our unique combination of investigations, integrated security systems and employment and background screening means we deliver the peace of mind that comes from knowing more.

Neurimmune Holding AG

Company profile page for Neurimmune Holding AG including stock price, company news, press releases, executives, board members, and contact information. Neurimmune collaborates with Biogen on multiple programs for neurodegenerative diseases and Biogen acquired rights in antibodies BIIB054 for Parkinson’s disease and BIIB076 for Alzheimer’s disease. In 2016, Neurimmune partnered with TVM and Eli Lilly’s Chorus unit to advance an antibody for the treatment of amyotrophic lateral sclerosis. RegenxBio partners with Neurimmune , expands gene therapy pipeline RegenxBio Inc. (NASDAQ:RGNX) and Neurimmune AG (Zurich, Switzerland) partnered to develop and commercialize gene therapies that use the formers NAV vectors to deliver antibodies to treat neurodegenerative...

nLife Therapeutics

You’re viewing a free company profile from the PitchBook Platform. To explore nLife Therapeutics’s full profile , request a free trial. nLife Therapeutics SL The Company develops nanotherapeutics for major depressive disorders, obesity, and oncology . nLife Therapeutics primarily operates in Spain. SECTOR nLife Therapeuticss detailed financings; Comprehensive pipeline breakdown, including molecular targets & partnerships. In-depth BioPharma industry analysis.

S.L.

Profile JOIN. Search. Hotels. Things to do. Restaurants. Flights. Vacation Rentals. Cruises. Rental Cars. Travel Forum. Airlines. Best of 2019. Road Trips. Help Center. Inbox. See all. Log in to get trip updates and message other travelers. ... s l wrote a review. Apr 2018. Good pairing with the tour of flager college. surcis , s.l . Surcis is a company specialized in respirometry systems and wastewater biological treatment processes. The compact and fast BM multipurpose respirometers are unique in the market. 34 rows · L profile , steel unequal angles , sections sizes, dimensions, properties, specifications …

reMYND NV

reMYND was founded in 2002 as a spin-off CRO from the University of Leuven. We strongly believe that, by taking the lead and working together, we can provide innovative solutions to address key challenges at the root that have shown to be unsolvable so far. About us. reMYND NV is a dynamic biotech company located in Leuven (Belgium) that actively drives R&D in the field of protein misfolding diseases, among others Alzheimer’s disease (AD) and ... A 3D cell-based model that encapsulates the two hallmark features of Alzheimers disease-neurofibrillary tangles and b-amyloid plaques-has been created by a team at Massachusetts General Hospital to help screen compounds for the disease. 1 Although...

Sangamo BioSciences

Sangamo uses a multi-platform approach to gene-based therapeutics with industry leading technologies in gene therapy, gene editing, cell therapy and gene regulation. Meet the leaders and learn more about Sangamo s latest developments. Aug 07, 2019 · Sangamo Therapeutics Inc. 501 Canal Blvd RICHMOND CA 94804-3559 P: +1510.9706000 F: +1302.6555049 Competitors of Sangamo BioSciences include BlueRock Therapeutics, PhaseBio Pharmaceuticals and Actinium Pharmaceuticals. Where is Sangamo BioSciences headquarters? Sangamo BioSciences headquarters is located at 501 Canal Blvd , Richmond .

Inc.

Visit Inc.com for the latest issue of Inc . Magazine and get advice, tools, and services that help your small business grow. An Inc. Verified Profile is the perfect tool for helping entrepreneurs and small companies showcase their companies in attention-grabbing context. Whether you want to drum up new customers, seek ... Aug 24, 2019 · Immunic Inc . company facts, information and stock details by MarketWatch. View imux business summary and other industry information.

UniQure N.V.

uniQure N.V., a gene therapy company, engages in the discovery, development, and commercialization of gene therapies in the Netherlands. The company develops AMT-060, which is in Phase I/II clinical trial to treat hemophilia B; AMT-061, a gene therapy that is in Phase III clinical trial for the treatment of hemophilia; and AMT-126,... How can the answer be improved? Aug 24, 2019 · uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntingtons disease, glybera, and cardiovascular problems .

Voyager Therapeutics

Aug 24, 2019 · Voyager Therapeutics Inc. company facts, information and stock details by MarketWatch. View vygr business summary and other industry information. Voyager Therapeutics to Appoint Omar Khwaja, M.D., Ph.D., as Chief Medical Officer Where Science and Patients Converge Voyager ’s mission is to develop and deliver life-changing therapies to people around the world living with severe neurological diseases. Voyager Therapeutics , Inc., incorporated on June 19, 2013, is a clinical-stage gene therapy company. The Company focuses on developing treatments for patients suffering from severe diseases of the ...

Inc.

Visit Inc.com for the latest issue of Inc . Magazine and get advice, tools, and services that help your small business grow. An Inc. Verified Profile is the perfect tool for helping entrepreneurs and small companies showcase their companies in attention-grabbing context. Whether you want to drum up new customers, seek ... Aug 24, 2019 · Immunic Inc . company facts, information and stock details by MarketWatch. View imux business summary and other industry information.

Vybion

Vybion is the leading developer of Intrabodies for neurodegenerative diseases, leveraging the safety and effectiveness of antibody technologies to address unmet medical needs. Vybion Intrabodies are scFv fragments that target and change the fate of intracellular events like the protein aggregation, gene dysregulation and turnover of toxic ... Company profile page for Vybion Inc including stock price, company news, press releases, executives, board members, and contact information. Information on valuation, funding, cap tables, investors, and executives for Vybion . Use the PitchBook Platform to explore the full profile .

Inc.

Visit Inc.com for the latest issue of Inc . Magazine and get advice, tools, and services that help your small business grow. An Inc. Verified Profile is the perfect tool for helping entrepreneurs and small companies showcase their companies in attention-grabbing context. Whether you want to drum up new customers, seek ... Aug 24, 2019 · Immunic Inc . company facts, information and stock details by MarketWatch. View imux business summary and other industry information.

WAVE Life Scienc

We would like to show you a description here but the site won’t allow us. See the company profile for Wave Life Sciences Ltd. (WVE) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and ... Aug 24, 2019 · Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the …

For More information, Please access Read the total report.